Atara Biotherapeutics, Inc. (ATRA)
NASDAQ · Healthcare
Atara Biotherapeutics, Inc. Net Income 2022–2025
Atara Biotherapeutics, Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Atara Biotherapeutics, Inc. net income for the quarter ending March 31, 2026 was -4.1 M, a 110.91% decrease year-over-year.
- Atara Biotherapeutics, Inc. net income for the twelve months ending March 31, 2026 was 31.9 M, a 122.42% decrease year-over-year.
- Atara Biotherapeutics, Inc. annual net income for 2025 was 32.7 M, a 138.28% decrease from 2024.
- Atara Biotherapeutics, Inc. annual net income for 2024 was -85.4 M, a 69.07% decrease from 2023.
- Atara Biotherapeutics, Inc. annual net income for 2023 was -276.1 M, a 20.95% increase from 2022.
- Atara Biotherapeutics, Inc. annual net income for 2022 was -228.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atara Biotherapeutics, Inc. Net Income — FAQ
Atara Biotherapeutics, Inc. (ATRA) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Atara Biotherapeutics, Inc.'s net income?
Atara Biotherapeutics, Inc. (ATRA) reported net income of $33M for fiscal 2025.
Where can I see ATRA's net income history?
The chart and table above show Atara Biotherapeutics, Inc.'s net income by year and by quarter, including the growth rate.